Search
for
Sort by
Research 361–390 of 482
- Mechanisms of autophagy and their implications in dermatological disorders
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review
- Combined drug triads for synergic neuroprotection in retinal degeneration
- Off-label uses of retinoids in dermatology
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- A Study of Correlation of Alopecia Areata and Metabolic Syndrome in Northwest Indian Population
- Cell-Based Model Systems for Validation of Various Efficacy-Based Claims for Cosmetic Ingredients
- Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling
- The Versatile Applications of Triple‐Wavelength Diode Laser (810, 940, and 1060 nm) in Aesthetic Treatments, Follicular Disorders, and Chronic Inflammatory Conditions in the Asian Population: Case Report Collection
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- The association of medications and supplements with human male reproductive health: a systematic review
- Bone Metabolism in Patients with Hidradenitis Suppurativa: A Case-control Study
- Hidradenitis suppurativa: A comparison of guidelines
- Treatment options for alopecia areata
- Cytokine Engineering Approaches for Regenerative Medicine
- Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity
- Premature hair graying: a multifaceted phenomenon
- Spironolactone in hidradenitis suppurativa: a single-center
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
- Abstracts
- Alopecia areata: medical treatments
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Multi-omics and AI-driven advances in miRNA-mediated hair follicle regulation in cashmere goats
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts